MeSH D016919 - cryptococcal meningitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Amphotericin b | Amphotericin B |  | 1995-03-31 |  |  |
| Fluconazole | Fluconazole |  | 2004-07-29 |  |  | |
| Taro Pharmaceutical | Fluconazole | Fluconazole |  | 2004-07-29 |  |  |
| Glenmark Pharmaceuticals | Fluconazole | Fluconazole |  | 2006-01-25 |  |  |
| Mylan | Fluconazole | Fluconazole |  | 2004-07-29 |  |  |
| Bausch Health Companies | Flucytosine | Ancobon |  | 1982-01-01 |  |  |
| Pfizer | Fluconazole | Diflucan |  | 1990-01-29 | $220 M | Y2014 |
| Aurobindo Pharma | Fluconazole | Fluconazole |  | 2008-10-07 |  |  |
| Flucytosine | Flucytosine |  | 2020-05-01 |  |  | |
| Dr Reddys Laboratories | Fluconazole | Fluconazole |  | 2004-07-29 |  |  |
| Zydus Therapeutics | Fluconazole | Fluconazole |  | 2017-02-16 |  |  |
| Sun Pharmaceutical Industries | Fluconazole | Fluconazole |  | 2004-07-29 |  |  |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
50%2/4
Phase 2
50%3/6
Phase 3
86%6/7
Approved: 3Overall Success rate: 21%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use